A blood test that can identify which patients will respond to breast cancer therapies has been developed by scientists at DCU, and could inform better decisions on patient treatments. Dr Denis Collins, Principal Investigator for the Cancer Biotherapeutics Research Group at the National Institute for Cellular Biotechnology at DCU, whose team carried out the work, […]